Many women have ovarian cysts at some time. Most ovarian cysts present little or no discomfort and are harmless. The majority disappears without treatment within a few months. However, ovarian cysts â especially those that have ruptured â can cause serious symptoms.
Aranesp is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
Aetna considers erythropoietin therapy (e.g., EPO, Epogen [epoetin alfa], Procrit, r-HuEPO) and darbepoietin alfa therapy (Aranesp) medically necessary when any of the following selection criteria is met (see Appendix for specific criteria): Anemia from myelodysplastic syndrome; or.